Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report
- PMID: 34453934
- PMCID: PMC8386136
- DOI: 10.1016/j.ajog.2021.08.025
Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report
References
-
- US Food and Drug Administration Fact sheet for healthcare providers: emergency use authorization (EUA) of REGEN-COV (casirivimab and imdevimab). 2021. https://www.fda.gov/media/145611/download Available at: Accessed Aug. 8, 2021.
-
- US Food and Drug Administration Fact sheet for health care providers emergency use authorization (EUA) OF BAMLANIVIMAB. 2021. https://www.fda.gov/media/143603/download#:∼:text=High%20risk%20is%20def... Available at: Accessed Aug. 8, 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources